Isolation, identification and antifungal susceptibility of Candida species in postmenopausal women
DOI:
https://doi.org/10.32792/utq/utjsci/v11i2.1241Keywords:
CHROM Agar; Candida Spp; Vulvovaginal CandidiasisAbstract
Abstract— The term "vulvovaginal candidiasis" refers to an inflammatory, non-erosive Vulvovaginitis characterized by symptoms such as itching, pain, dyspareunia, and discharge. The condition is treated with antifungal medication if a positive culture from a low vaginal swab reveals Candida. It should be mentioned that these people had ongoing medical conditions. VVC had previously been classified as acute or recurring. It appears that estrogen is a key permissive factor in VVC. Clinical findings have demonstrated that VVC is uncommon in premenopausal and postmenopausal women and that the post-menopausal vagina rarely contains isolated Candida. The study aimed to know the relationship between Vulvovaginitis and candida in postmenopausal women and effectiveness of some antifungals. A total of 100 postmenopausal women With Vulvovaginitis, aged 45 to 69, had vaginal swabs taken from them. Upon arrival at the laboratory, all samples were cultured on Sabouraud dextrose agar . The species of the isolated yeasts were identified by a variety of methods, including molecular analysis with primers ITS1–ITS4, growth on Chrom agar medium, and biochemical analyses. Result: candida in postmenopausal women is less than in per menopausal due to effectiveness of estrogen hormone in reproductive age . The outcomes On Chrom agar showed, six species of candida—C. albicans, C. glabrata, C. tropicalis, C. parapsilosis, C. krusei, and c. rugosa—were isolated. Among the other species, C. glabrata was discovered to be the most prevalent. The findings demonstrated that four species of yeast-like fungi were identified using molecular diagnosis and genetic testing as follows:
Received: 2024-05-02
Revised: 2024-05-25
Accepted: 2024-06-04
References
V. L. Katz, Comprehensive Gynecology. Mosby, 2007.
D. Poulain, “Candida Albicans, Plasticity And Pathogenesis,” Crit. Rev. Microbiol., Vol. 41, No. 2,. 208–217, 2015.
J.-M. Kim And Y. J. Park, “Probiotics In The Prevention And Treatment Of Postmenopausal Vaginal Infections,” J. Menopausal Med., Vol. 23, No. 3,. 139, 2017.
D. F. Archer, “Efficacy And Tolerability Of Local Estrogen Therapy For Urogenital Atrophy,” Menopause, Vol. 17, No. 1,. 194–203, 2010.
R. E. Nappi And S. Palacios, “Impact Of Vulvovaginal Atrophy On Sexual Health And Quality Of Life At Postmenopause,” Climacteric, Vol. 17, No. 1,. 3–9, 2014, Doi: 10.3109/13697137.2013.871696.
O. Makanjuola, F. Bongomin, And S. A. Fayemiwo, “An Update On The Roles Of Non-Albicans Candida Species In Vulvovaginitis,” J. Fungi, Vol. 4, No. 4, 2018, Doi: 10.3390/Jof4040121.
D. Aljaza, “Effect Of Gaseous Ozone (O3) On Artificial Population And Aflatoxin B1 Production By Aspergillus Flavus In Stored Whole Cinnamon In Iraqi Markets,” Indian J. Forensic Med. Toxicol., Vol. 14, No. 4, 1516–1521, 2020.
D. S. Jabar, “Conventional And Molecular Identification Of Candida Spp . And Antifungals Susceptibility Test In Pregnant Women,” No. 2, 13–20, 2022.
R. Samy and D. Aljaza, “Identification Of Candidaspecies Isolated From Oral Pediatric And Identification Of Its Sensitivity To Some Antifungals,” Univ. Thi-Qar J. Sci., Vol. 10, No. 1, 2023.
P. Savetha, V. Illamani, and B. K. Madhusudhanan, “Prevalence Of Vulvovaginal Candidiasis Among Pre and Post-Menopausal Diabetic And Non-Diabetic Women,” Vol. 25, No. 1,. 3014–3044, 2021.
E. L. Berkow, S. R. Lockhart, And L. Ostrosky-Zeichner, “Crossm Antifungal Susceptibility Testing : Current Approaches,” Vol. 33, No. 3,. 1–30, 2020.
N. C. Nwokolo And F. C. Boag, “Chronic Vaginal Candidiasis. Management In The Postmenopausal Patient,” Drugs And Aging, Vol. 16, No. 5, Pp. 335–339, 2000, Doi: 10.2165/00002512-200016050-00003.
J. D. Mintz And M. G. Martens, “Prevalence Of Non- Albicans Candida Infections In Women With Recurrent Vulvovaginal Symptomatology,” Vol. 2013, No. December,. 238–242, 2013.
G. Fischer And J. Bradford, “Vulvovaginal Candidiasis In Postmenopausal Women: The Role Of Hormone Replacement Therapy,” J. Low. Genit. Tract Dis., Vol. 15, No. 4,. 263–267, 2011, Doi: 10.1097/Lgt.0b013e3182241f1a.
R. H. Beigi, L. A. Meyn, D. M. Moore, M. A. Krohn, And S. L. Hillier, “Vaginal Yeast Colonization In Nonpregnant Women: A Longitudinal Study,” Obstet. Gynecol., Vol. 104, No. 5 Part 1,. 926–930, 2004.
J. N. Hoffmann, H. M. You, E. C. Hedberg, J. A. Jordan, And M. K. Mcclintock, “Prevalence Of Bacterial Vaginosis And Candida Among Postmenopausal Women In The United States,” Vol. 69,. 205–214, 2014, Doi: 10.1093/Geronb/Gbu105.
J. D. Sobel, “Vaginal Infections In Adult Women,” Med. Clin. North Am., Vol. 74, No. 6,. 1573–1602, 1990.
S. Khadka et al., “Isolation, Speciation And Antifungal Susceptibility Testing Of Candida Isolates From Various Clinical Specimens At A Tertiary Care Hospital, Nepal,” Bmc Res. Notes, Vol. 10,. 1–5, 2017.
R. Goswami et al., “Species-Specific Prevalence Of Vaginal Candidiasis Among Patients With Diabetes Mellitus And Its Relation To Their Glycaemic Status,” J. Infect., Vol. 41, No. 2,. 162–166, 2000.
D. Ray et al., “Prevalence Of Candida glabrata And Its Response To Boric Acid Vaginal Suppositories In Comparison With Oral Fluconazole In Patients With Diabetes And Vulvovaginal Candidiasis,” Diabetes Care, Vol. 30, No. 2,. 312–317, 2007.
M. M. A. Nagla, O. E. El Fadil, A. H. M. Muzamil, A. N. Hisham, M. B. Bahaeldeen, And E.-A. El-Nour, “Internal Transcribed Spacer For Identification Of Yeast Species Isolated From Cancer Patients At The Isotope And Radiation Center, Khartoum, Sudan: A Cross-Sectional, Case-Control Study,” F1000research, Vol. 7. 443, 2018.
S. Farahyar, Z. G. Mobaser, E. Razmjou, M. Roudbary, M. Rahimi, And A. Fattahi, “Molecular Investigation Of Etiologic Agents Causing Vulvovaginal Candidiasis,” Jundishapur J. Microbiol., Vol. 13, No. 8, 2020.
A. B. Mohammed, J. H. Ali, S. K. Abdullah, And A. B. Mohammed, “Identification Of Candida Spp . Isolated From Vaginal Swab By Phenotypic Methods And Multiplex Pcr In Duhok , Iraq,” Vol. 3, No. 11, 3211–3216, 2015.
Z. S. Oufi, A. B. Mohammed, And S. K. Abdullah, “Oufi, Mohammed And Abdullah, 2022,” 2022.
S. D. Waikhom et al., “Prevalence Of Vulvovaginal Candidiasis Among Pregnant Women In The Ho Municipality, Ghana: Species Identification And Antifungal Susceptibility Of Candida Isolates,” Bmc Pregnancy Childbirth, Vol. 20,. 1–14, 2020.
G. N. B. Brito, A. C. Inocêncio, S. M. R. Querido, A. O. C. Jorge, And C. Y. Koga-Ito, “In Vitro Antifungal Susceptibility Of Candida Spp. Oral Isolates From Hiv-Positive Patients And Control Individuals,” Braz. Oral Res., Vol. 25, 28–33, 2011.
M. M. Ahmed, H. Hanan, K. S. Sohair, M. Maha, M. Doaa, And Z. Mohammed, “Identification And In Vitro Susceptibility Pattern Of Fungal Pathogens In Immunocomprimised Patients With Pulmonary Fungal Infections,” Med. J. Cairo Univ., Vol. 86, No. December,. 4307–4316, 2018.
A. Arastehfar et al., “Incidence And Spectrum Of Yeast Species Isolated From The Oral Cavity Of Iranian Patients Suffering From Hematological Malignancies,” J. Oral Microbiol., Vol. 11, No. 1,. 1601061, 2019.
M. Del Rocío Reyes-Montes, E. Duarte-Escalante, E. Martínez-Herrera, G. Acosta-Altamirano, And M. G. Frías-De León, “Revista Iberoamericana De Micología,” Rev Iberoam Micol, Vol. 34, No. 4, 2017.
Downloads
Published
License
Copyright (c) 2024 University of Thi-Qar Journal of Science
This work is licensed under a Creative Commons Attribution 4.0 International License.
